Compare EML & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EML | TMCI |
|---|---|---|
| Founded | 1858 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.2M | 120.4M |
| IPO Year | 1995 | 2021 |
| Metric | EML | TMCI |
|---|---|---|
| Price | $18.36 | $1.97 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.21 |
| AVG Volume (30 Days) | 11.3K | ★ 542.2K |
| Earning Date | 01-01-0001 | 04-03-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | ★ $272,751,967.00 | $209,357,000.00 |
| Revenue This Year | $1.56 | $3.30 |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | $18.87 | ★ N/A |
| Revenue Growth | N/A | ★ 11.89 |
| 52 Week Low | $17.61 | $1.81 |
| 52 Week High | $28.75 | $10.03 |
| Indicator | EML | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 39.63 |
| Support Level | $17.81 | $1.81 |
| Resistance Level | $19.05 | $3.06 |
| Average True Range (ATR) | 0.54 | 0.14 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 10.60 | 38.38 |
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.